Literature DB >> 32297907

The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings.

Massimo Di Maio1,2, Marco Audisio1,2, Claudia Cardone3,4, Emmanuele De Luca1,2, Piera Gargiulo3, Clizia Zichi1,2, Francesco Perrone3.   

Abstract

Mesh：

Year:  2020        PMID： 32297907      PMCID： PMC7163776          DOI： 10.1001/jamaoncol.2020.0475

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Reporting of subgroup analyses from clinical trials.

Authors:  Maria Pia Sormani; Paolo Bruzzi
Journal:  Lancet Neurol       Date:  2012-09       Impact factor: 44.182

2.  The Use of "Trend" Statements to Describe Statistically Nonsignificant Results in the Oncology Literature.

Authors:  Kevin T Nead; Mackenzie R Wehner; Nandita Mitra
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

3.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

4.  Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.

Authors:  F E Vera-Badillo; R Shapiro; A Ocana; E Amir; I F Tannock
Journal:  Ann Oncol       Date:  2013-01-09       Impact factor: 32.976
  4 in total
  1 in total

1.  Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer.

Authors:  Yi Xiao; Jiahan Ding; Dachang Ma; Sheng Chen; Xun Li; Keda Yu
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.